Now in its 18th Year, BioCentury is recognized as the ESSENTIAL provider of independent, informed business intelligence that regularly affects decisions made by bio-industry leaders and investors throughout the world.

BioCentury's mission is to provide value-added information and analysis for biotech and pharma companies, investors, academia and government on the strategic issues essential to the formation, development and sustainability of biopharmaceutical ventures.

Our breadth of coverage includes corporate strategy, partnering, emerging technology, clinical data, public policy and the financing markets.